Combination therapy for COPD

PK201001064A0Active Publication Date: 2011-01-08CHIESI FARMACEUTICI SPA
0 Cites 0 Cited by

Patent Information

Application Number
PK201001064
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2010-12-21
Publication Date
2011-01-08
Patent Text Reader

Abstract

The invention concerns an aerosol composition suitable for administering to chronic obstructive pulmonary disease (COPD) patients by means of a pressurized metered dose inhaler (pMDI), comprising glycopyrronium bromide in combination with formoterol. The composition further comprises a HFA propellant, a co-solvent, and an amount of inorganic acid sufficient to stabilize both the glycopyrronium bromide and the formoterol components. Optionally the composition further comprises beclometasone dipropionate.
Need to check novelty before this filing date? Find Prior Art